Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Emicizumab and asparaginase, A first experience to share.
Goubeau L, Bally C, Borgel D, Alby-Laurent F, Petit A, Frenzel L, Lasne D, Harroche A. Goubeau L, et al. Among authors: bally c. Haemophilia. 2024 Mar;30(2):561-563. doi: 10.1111/hae.14935. Epub 2024 Jan 19. Haemophilia. 2024. PMID: 38240017 No abstract available.
Systematic search for the UBA1 mutation in men after a first episode of venous thromboembolism: A monocentric study.
Khider L, Templé M, Bally C, Spaeth A, Darnige L, Sanchez O, Planquette B, Mortelette H, Messas E, Smadja DM, Emmerich J, Mirault T, Kosmider O, Gendron N. Khider L, et al. Among authors: bally c. J Thromb Haemost. 2022 Nov;20(11):2697-2699. doi: 10.1111/jth.15858. Epub 2022 Sep 13. J Thromb Haemost. 2022. PMID: 36002395 Free PMC article. No abstract available.
Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control study.
Péan de Ponfilly-Sotier M, Jachiet V, Benhamou Y, Lahuna C, De Renzis B, Kottler D, Voillat L, Dimicoli-Salazar S, Banos A, Chauveheid MP, Alexandra JF, Grignano E, Liferman F, Laborde M, Broner J, Michel M, Lambotte O, Laribi K, Venon MD, Dussol B, Martis N, Thepot S, Park S, Couret D, Roux-Sauvat M, Terriou L, Hachulla E, Bally C, Galland J, Allain JS, Parcelier A, Peterlin P, Cohen-Bittan J, Regent A, Ackermann F, Le Guen J, Algrin C, Charles P, Daguindau E, Puechal X, Dunogue B, Blanchard-Delaunay C, Beyne-Rauzy O, Grobost V, Schmidt J, Le Gallou T, Dubos-Lascu G, Sonet A, Denis G, Roy-Peaud F, Fenaux P, Adès L, Fain O, Mekinian A; MINHEMON (French Network of Dysimmune Disorders Associated wit Hemopathies) and GFM. Péan de Ponfilly-Sotier M, et al. Among authors: bally c. Clin Exp Rheumatol. 2022 Jul;40(7):1336-1342. doi: 10.55563/clinexprheumatol/nbn38d. Epub 2022 May 16. Clin Exp Rheumatol. 2022. PMID: 35579092 Free article.
Emicizumab does not interfere with the activated clotting time.
Capdevila L, Frère C, Desvages M, Harroche A, Bally C, Abbes A, d'Oiron R, Frenzel L, Borgel D, Lasne D. Capdevila L, et al. Among authors: bally c. Haemophilia. 2022 Mar;28(2):362-366. doi: 10.1111/hae.14497. Epub 2022 Jan 21. Haemophilia. 2022. PMID: 35060654
45 results